Thrombopoietin mimetics vs placebo
Blood transfusion requirements · Adult patients with myelodysplastic syndromes and thrombocytopenia
Thrombopoietin mimetics showed no clear difference in transfusion requirement compared with placebo (low certainty).
1 finding from 1 review
- Thrombopoietin mimetics for patients with myelodysplastic syndromes 2017 · Cochrane Headline outcomes onlyRR 0.83 [0.66, 1.05]4 studies · 358 participantsLow